LU90004I2 - Levovist - Google Patents

Levovist

Info

Publication number
LU90004I2
LU90004I2 LU90004C LU90004C LU90004I2 LU 90004 I2 LU90004 I2 LU 90004I2 LU 90004 C LU90004 C LU 90004C LU 90004 C LU90004 C LU 90004C LU 90004 I2 LU90004 I2 LU 90004I2
Authority
LU
Luxembourg
Prior art keywords
microparticles
levovist
myocardium
spleen
organs
Prior art date
Application number
LU90004C
Other languages
French (fr)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of LU90004I2 publication Critical patent/LU90004I2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Acoustics & Sound (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Air Conditioning Control Device (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Gyroscopes (AREA)
  • Steroid Compounds (AREA)

Abstract

Contrast agents for ultrasonic diagnosis consisting of gas bubbles and microparticles are described and are characterised in that they contain as microparticles a mixture of at least one (C10-C20)-fatty acid with at least one solid which has no interfacial activity, suspended in a liquid vehicle. They provide contrast in ultrasonic imaging of the right and left heart, the myocardium and other organs such as the liver, spleen and kidney, after intravenous administration.
LU90004C 1988-10-07 1997-01-08 Levovist LU90004I2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3834705A DE3834705A1 (en) 1988-10-07 1988-10-07 ULTRASONIC CONTRASTING AGENTS FROM GAS BUBBLES AND MICROPARTICLES CONTAINING FATTY ACID

Publications (1)

Publication Number Publication Date
LU90004I2 true LU90004I2 (en) 1997-03-04

Family

ID=6364930

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90004C LU90004I2 (en) 1988-10-07 1997-01-08 Levovist

Country Status (19)

Country Link
EP (1) EP0365467B1 (en)
JP (1) JPH0737394B2 (en)
KR (1) KR970001433B1 (en)
CN (1) CN1027575C (en)
AT (1) ATE93145T1 (en)
AU (1) AU627456B2 (en)
CA (1) CA1338507C (en)
DE (2) DE3834705A1 (en)
DK (1) DK99789A (en)
ES (1) ES2059814T3 (en)
FI (1) FI100170B (en)
IE (1) IE65243B1 (en)
IL (1) IL90028A (en)
LU (1) LU90004I2 (en)
NL (1) NL970009I2 (en)
NO (2) NO178139C (en)
NZ (1) NZ228781A (en)
PT (1) PT91523B (en)
ZA (1) ZA892885B (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE151993T1 (en) * 1991-07-05 1997-05-15 Nycomed Imaging As IMPROVEMENTS TO CONTRAST AGENTS
MX9205298A (en) * 1991-09-17 1993-05-01 Steven Carl Quay GASEOUS ULTRASOUND CONTRASTING MEDIA AND METHOD FOR SELECTING GASES TO BE USED AS ULTRASOUND CONTRASTING MEDIA
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
HU218018B (en) * 1991-09-17 2000-05-28 Sonus Pharmaceuticals Inc. Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
US5196183A (en) * 1991-12-04 1993-03-23 Sterling Winthrop Inc. Contrast agents for ultrasound imaging
GB9200387D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
WO1994016739A1 (en) * 1993-01-25 1994-08-04 Sonus Pharmaceuticals, Inc. Phase shift colloids as ultrasound contrast agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
GB9402867D0 (en) * 1994-02-15 1994-04-06 Nycomed Imaging As Improvements in or relating to contrast agents
DE4406474A1 (en) * 1994-02-23 1995-08-24 Schering Ag Gas-containing microparticles, agents containing them, their use in ultrasound diagnostics, and methods for producing the particles and agents
US5876697A (en) * 1994-08-04 1999-03-02 Gakko Houjin Toin Gakuen Method for the production of microbubble-type ultrasonic contrast agent using fatty acid surfactants
DE19602930A1 (en) * 1996-01-18 1997-07-24 Schering Ag Porous matrices made of low molecular weight substances for the generation of stable gas bubble suspensions, their use as ultrasound contrast agents and processes for their production
GB9808582D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
WO2000021578A1 (en) 1998-10-12 2000-04-20 Mallinckrodt Inc. Novel ultrasound contrast agents
DE19950311A1 (en) * 1999-10-13 2001-04-19 Schering Ag Stable storage of parenteral ultrasonic contrast agent formulation, using vial closed with dry stopper to prevent reduction of in vivo effectiveness
DE19952738A1 (en) * 1999-10-27 2001-05-23 Schering Ag Improved suspensions of ultrasound contrast media
EP2279757A3 (en) 2000-06-02 2011-08-03 Bracco Suisse SA Compounds for targeting endothelial cells
AU2002253454A1 (en) 2001-04-06 2002-10-21 Bracco Research S.A. Method for improved measurement of local physical parameters in afluid-filled cavity
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
JP2006514915A (en) 2002-03-01 2006-05-18 ダイアックス、コープ KDR and VEGF / KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
SI2949658T1 (en) 2003-03-03 2018-10-30 Dyax Corp. Peptides that specifically bind HGF receptor (cMet) and uses thereof
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
KR101001547B1 (en) 2004-01-28 2010-12-17 삼성에스디아이 주식회사 A fabric solar cell and a method for preparing the same
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
JP5196896B2 (en) * 2007-07-13 2013-05-15 花王株式会社 Method for producing fine bubble precursor
WO2021141595A1 (en) * 2020-01-10 2021-07-15 Advanced Microbubbles Laboratories Llc Preparation and preservation of collagen microbubbles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640271A (en) 1969-06-30 1972-02-08 Ibm Blood flow pressure measurement technique employing injected bubbled and ultrasonic frequency scanning
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4265251A (en) 1979-06-28 1981-05-05 Rasor Associates, Inc. Method of determining pressure within liquid containing vessel
WO1982001642A1 (en) 1980-11-17 1982-05-27 Med Inc Ultra Microbubble precursors and methods for their production and use
DE3141641A1 (en) 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen ULTRASONIC CONTRAST AGENTS AND THEIR PRODUCTION
JPS5920532A (en) * 1982-07-23 1984-02-02 Nippon Denso Co Ltd Method of controlling quantity of fuel for internal combustion engine on vehicle
DE3313947A1 (en) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS
DE3313946A1 (en) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS
DE3637926C1 (en) * 1986-11-05 1987-11-26 Schering Ag Ultrasonic manometry in a liquid using microbubbles

Also Published As

Publication number Publication date
CA1338507C (en) 1996-08-06
CN1027575C (en) 1995-02-08
AU3390089A (en) 1990-04-12
NO890609L (en) 1990-04-09
DK99789D0 (en) 1989-03-01
FI890749A0 (en) 1989-02-16
EP0365467A3 (en) 1990-06-06
JPH0737394B2 (en) 1995-04-26
IE65243B1 (en) 1995-10-04
DE58905318D1 (en) 1993-09-23
AU627456B2 (en) 1992-08-27
KR900005939A (en) 1990-05-07
PT91523A (en) 1990-04-30
IL90028A (en) 1993-01-31
IL90028A0 (en) 1989-12-15
NL970009I2 (en) 1997-08-01
NZ228781A (en) 1992-03-26
KR970001433B1 (en) 1997-02-06
ZA892885B (en) 1990-12-28
IE891149L (en) 1990-04-07
ATE93145T1 (en) 1993-09-15
NO178139C (en) 1996-01-31
NO1998014I1 (en) 1998-05-05
JPH02145528A (en) 1990-06-05
PT91523B (en) 1995-05-31
NL970009I1 (en) 1997-05-01
FI100170B (en) 1997-10-15
FI890749A (en) 1990-04-08
ES2059814T3 (en) 1994-11-16
EP0365467A2 (en) 1990-04-25
NO890609D0 (en) 1989-02-13
DK99789A (en) 1990-04-08
NO178139B (en) 1995-10-23
CN1044225A (en) 1990-08-01
EP0365467B1 (en) 1993-08-18
DE3834705A1 (en) 1990-04-12

Similar Documents

Publication Publication Date Title
LU90004I2 (en) Levovist
Walsh et al. Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia
CA2211100A1 (en) Diagnostic imaging contrast agents with extended blood retention
DE3764253D1 (en) MEDICAL SUCTION BODY WITH X-RAY CONTRAST AGENT AND METHOD FOR THE PRODUCTION THEREOF.
IL97411A (en) Pharmaceutical formulations comprising hapten-modified diagnostic or therapeutic agents
ES2052766T3 (en) MAGNETIC COMPOSITIONS IN LIQUID STATE.
FI884051A0 (en) Method for preparing stabilized human protein preparations
CA2107556A1 (en) Increasing blood-brain barrier permeability with permeabilizer peptides
CA2100256A1 (en) A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion,and the use of said agents for said purpose
MA21264A1 (en) COMPOSITION FOR ADMINISTERING MEDICAMENT IN THE FORM OF CELLS, POWDER OR LIQUID.
Kobayashi et al. Influence of contrast ultrasonography with perflutren lipid microspheres on microvessel injury
Marriott Dependence on antiparkinsonian drugs.
Bertuglia Increase in capillary perfusion following low-intensity ultrasound and microbubbles during postischemic reperfusion
Ree et al. Laboratory diagnosis of malaria.
Chaudhuri et al. Uptake of 87mSr by liver metastasis from carcinoma of colon
Roth et al. Lipemia-Induced Acceleration of Intravascular Clotting.
JOHANSSON et al. 6‐Hydroxydopamine and the blood‐brain barrier in adult conscious rats
KR100373712B1 (en) Contrast agent and manufacturing method of same
Valli et al. Pathology of T. congolense in calves
Boulton How much can ancillaries take over?
JPH035401A (en) Immobilization of specimen of organism
ENEMAS be taught is diminishing, partly as increasing
BONTE et al. EXPERIMENTAL STUDIES OF THE SPLANCHNIC CIRCULATION OF THE RABBIT AFTER LIGATION OF THE SUPERIOR MESENTERIC ARTERY: II: RADIONUCLIDE TRACER STUDIES
Padron et al. Incorporation Studies of Iodine131 Labeled Chemically Treated Bovine Plasma
Spiess Epidemiological Studies on super (224) Ra-Treated Patients.